At a glance
- Originator Tanabe Seiyaku
- Class Antiulcers; Gastric antisecretories
- Mechanism of Action Proton pump inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Peptic ulcer
Most Recent Events
- 03 Nov 1998 No-Development-Reported for Peptic ulcer in Japan (Unknown route)
- 26 Jul 1996 New profile
- 26 Jul 1996 Preclinical development for Peptic ulcer in Japan (Unknown route)